We screen for G6PD deficiency, kidney issues, and other contraindications before treatment
Gut hormones in POTS and their relation to hemodynamic parameters and gastrointestinal symptoms
CrossRef ABT-737 efficiently inhibits hepatocellular carcinoma cell activity via regulating PANoptosis Bi Deng, Xuefeng Jin, Dongmei Ye, Hefang Liu, Yunyun Qin, Xiaoyu Chen Discover Oncology .2026;[Epub] CrossRef Selinexor enhances the sensitivity of hepatocellular carcinoma cells to sorafenib by regulating the BAX/Bcl-2/PUMA apoptotic pathway and the XPO1/p27 cell cycle pathway Shenghong Du, Ling Wang, Chen Chen, Yu Sun, Qian Liu, Jingfei Shi, Feng Zhang, Kai Wang, Chao Cui Frontiers in Oncology .2026;[Epub] CrossRef Juglans mandshurica-Eleutherococcus senticosus herb pair inhibits hepatocellular carcinoma growth by inducing immunogenic cell death via the HIF-1/STAT3 pathway Yu Jiang, Lili Jiang, He Zhang, Huiming Lv, Lina Xu, Linlin Zheng, Shengjin Yu Fitoterapia .2026
The majority of insurance plans specifically exclude coverage for weight loss medications, even when prescribed by a physician for obesity management
May increase feelings of fullness , which can support reduced food intake
